# Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health

> **NCT00200824** · PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)**

## Conditions studied

- Breast Cancer
- Prostate Cancer

## Interventions

- **DRUG:** Soy Isoflavone Nutritional Supplements

## Key facts

- **NCT ID:** NCT00200824
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2009-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200824, "Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00200824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
